Influence of membranes on morbidity

Area of Science:

• Nephrology
• Biomaterials Science
• Clinical Medicine

Background:

• Haemodialysis, while life-extending, presents acute and chronic complications impacting patient morbidity and mortality.
• These complications are linked to dialysate composition and dialysis membranes.
• Biocompatible membranes are investigated for their potential to mitigate these issues.

Purpose of the Study:

• To evaluate the benefits of biocompatible membranes in haemodialysis.
• To assess impacts on nutritional status, infection rates, cardiovascular effects, and long-term outcomes.
• To review renoprotective effects and survival rates in acute renal failure patients.

Main Methods:

• Literature review of studies on biocompatible dialytic membranes.
• Analysis of prospective randomized controlled trials in chronic and acute renal failure.
• Evaluation of clinical data regarding biological reactions and patient outcomes.

Main Results:

• Evidence suggests biocompatible membranes, particularly synthetic ones, may offer advantages.
• Clinical data linking specific biological reactions to diseases are limited, and impact on clinical status is debated.
• Conflicting results exist for chronic renal failure patients; however, acute renal failure trials highlight biocompatible membrane importance.
• Cuprophane membranes remain cost-effective, especially for acute renal failure.

Conclusions:

• The clinical impact of biocompatible membranes requires further investigation through large, long-term trials.
• Despite challenges in conducting such trials, evidence supports the importance of biocompatible membranes, especially in acute renal failure.
• Cost remains a factor favoring cuprophane membranes in specific patient populations.